We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.
Journal article
Lancet Oncol
09/2014
15
1058 - 1059
Aged, Androgen Antagonists, Benzamides, Cost-Benefit Analysis, Health Care Costs, Humans, Male, Middle Aged, National Health Programs, Neoplasm Invasiveness, Neoplasm Recurrence, Local, Neoplasm Staging, Nitriles, Phenylthiohydantoin, Practice Guidelines as Topic, Prostatic Neoplasms, United States